Osteoarthritis of the knee
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with knee osteoarthritis who meet the diagnostic criteria of Western medicine; (2) Age 40-70 years old (including 40 and 70) male and female; (3)VAS score =3 =8 points; (4) The subject is informed and signs the informed consent voluntarily.
Exclusion criteria
Exclusion criteria: (1) Other inflammatory painful diseases of the knee joint such as rheumatoid arthritis psoriatic arthritis gout tumor villonodular synovitis joint trauma suppurative arthritis tuberculous arthritis; (2) Osteoarthritis caused by osteomyelitis bone tumor and bone tuberculosis; (3) Patients with suppurative non-specific and other infectious knee arthritis; (4) late joint deformity or disability; (5) Patients with multiple lower limb osteoarthritis combined with hip knee and ankle and lower limb arthralgia caused by the onset of lumbar degenerative diseases; (6) Patients with severe cardiovascular and cerebrovascular diseases (such as myocardial infarction stroke etc.) blood system (such as bleeding tendency coagulation dysfunction etc.) liver gastrointestinal kidney diseases and diabetes that researchers judge can affect treatment efficacy and safety; (7) Mentally ill persons; (8) Patients with systemic infection or in the treatment period of infectious diseases at the time of screening; (9) Intra-articular treatment including intra-articular drug injection joint cavity irrigation and arthroscopic surgery was performed within 3 months before screening; (10) Patients who had used hormone therapy within one month before screening; (11) Patients who had used non-steroidal anti-inflammatory drugs glucosamine chondroitin sulfate or other drugs for the treatment of knee osteoarthritis and related Chinese medicines within 3 weeks before screening; (12) Pregnant or lactating women; (13) People with allergies; (14) Patients who had participated in other clinical trials within three months prior to screening; (15) The researchers considered that the candidates should not be included in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| WOMAC pain score and total score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain relief time;Pain removal time;SF-36; | — |
Countries
China
Contacts
The First Affiliated Hospital of Hunan University of Chinese Medicine